Abstract:Importance: Lung cancer screening with chest computed tomography (CT) prevents lung cancer death; however, fewer than 5% of eligible Americans are screened. CXR-LC, an open-source deep learning tool that estimates lung cancer risk from existing chest radiograph images and commonly available electronic medical record (EMR) data, may enable automated identification of high-risk patients as a step toward improving lung cancer screening participation. Objective: To validate CXR-LC using EMR data to identify individuals at high-risk for lung cancer to complement 2022 US Centers for Medicare & Medicaid Services (CMS) lung cancer screening eligibility guidelines. Design, setting, and participants: This prognostic study compared CXR-LC estimates with CMS screening guidelines using patient data from a large US hospital system. Included participants were persons who currently or formerly smoked cigarettes with an outpatient posterior-anterior chest radiograph between January 1, 2013, and December 31, 2014, with no history of lung cancer or screening CT. Data analysis was performed between May 2021 and June 2022. Exposures: CXR-LC lung cancer screening eligibility (previously defined as having a 3.297% or greater 12-year risk) based on inputs (chest radiograph image, age, sex, and whether currently smoking) extracted from the EMR. Main outcomes and measures: 6-year incident lung cancer. Results: A total of 14 737 persons were included in the study population (mean [SD] age, 62.6 [6.8] years; 7154 [48.5%] male; 204 [1.4%] Asian, 1051 [7.3%] Black, 432 [2.9%] Hispanic, 12 330 [85.2%] White) with a 2.4% rate of incident lung cancer over 6 years (361 patients with cancer). CMS eligibility could be determined in 6277 patients (42.6%) using smoking pack-year and quit-date from the EMR. Patients eligible by both CXR-LC and 2022 CMS criteria had a high rate of lung cancer (83 of 974 patients [8.5%]), higher than those eligible by 2022 CMS criteria alone (5 of 177 patients [2.8%]; P < .001). Patients eligible by CXR-LC but not 2022 CMS criteria also had a high 6-year incidence of lung cancer (121 of 3703 [3.3%]). In the 8460 cases (57.4%) where CMS eligibility was unknown, CXR-LC eligible patients had a 5-fold higher rate of lung cancer than ineligible (127 of 5177 [2.5%] vs 18 of 2283 [0.5%]; P < .001). Similar results were found in subgroups, including female patients and Black persons. Conclusions and relevance: Using routine chest radiographs and other data automatically extracted from the EMR, CXR-LC identified high-risk individuals who may benefit from lung cancer screening CT.

Cross-site validation of lung cancer diagnosis by electronic nose with deep learning: a multicenter prospective study

An Electronic Nose-Based Assistive Diagnostic Prototype for Lung Cancer Detection with Conformal Prediction

Development Of Electronic Nose For Diagnosis Of Lung Cancer At Early Stage

The Research of Electronic Nose and Diagnosis Model for Clinical Breath Diagnosis of Lung Cancer

Electronic Nose for Detecting Lung Cancer Based on Virtual Gas Sensor Array

A Portable Electronic Nose Intended for Home Healthcare Based on a Mixed Sensor Array and Multiple Desorption Methods

Recognizing lung cancer and stages using a self-developed electronic nose system

A Study on Electronic Nose for Clinical Breath Diagnosis of Lung Cancer

A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method

Prediction of lung cancer with a sensor array based e-nose system using machine learning methods

Diagnosis and Correlation Analysis of Lung Cancer Based on Multi-Parameter Regression of Respiratory Volatile Organic Compounds

Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.

Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision in imbalanced data

A Hybrid Electronic Noses' System Based on Mos-Saw Detection Units Intended for Lung Cancer Diagnosis

Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath

Deep Learning Empowers Lung Cancer Screening Based on Mobile Low-Dose Computed Tomography in Resource-Constrained Sites

An improved AdaBoost algorithm for identification of lung cancer based on electronic nose

An Electronic Nose Based on Hybrid MOS-SAW Sensors for Detection of Different Biomarkers of Lung Cancer

Validation of a Deep Learning-Based Model to Predict Lung Cancer Risk Using Chest Radiographs and Electronic Medical Record Data

Recent advances in signal processing algorithms for electronic noses

Computer-aided diagnosis of lung carcinoma using deep learning - a pilot study